The company's financial position appears increasingly vulnerable, with a retained earnings deficit exceeding $1.7 billion and a cash balance that has dwindled to $288.3 million as of 2026Q1.
| Total Current Assets | 1.27B | 1.27B | 878.15M | 1.21B | 1.09B | 1.27B | 308.32M | 94.54M | 148.28M | 2.04M |
| Cash & Short-Term Investments | 1.21B | 1.25B | 850.74M | 1.19B | 1.08B | 965.65M | 299.67M | 91.85M | 146.44M | 1.9M |
| Cash Only | 288.29M | 294.94M | 281.97M | 435.89M | 232.77M | 559.99M | 162.17M | 37.22M | 146.44M | 1.9M |
| Short-Term Investments | 923.36M | 950.27M | 568.77M | 753.98M | 845.37M | 405.65M | 137.5M | 54.63M | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 300M | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | 2.11K | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 55.3M | 0 | 27.41M | 21.17M | 14.76M | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 213.84M | 212.49M | 225.68M | 248.67M | 248.82M | 201.45M | 143.36M | 61.55M | 18.74M | 365K |
| Property, Plant & Equipment | 199.4M | 205.18M | 216.28M | 237.81M | 234.13M | 186.98M | 125.37M | 43.25M | 16.94M | 335K |
| Fixed Asset Turnover | 0.65x | 0.68x | 0.29x | 1.59x | 0.26x | 0.28x | 0.00x | 0.00x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 6.68M | 6.68M | 0 | 0 | 0 | 0 | 0 | 0 | 1.49M | 30K |
| Other Non-Current Assets | 14.45M | 634K | 9.4M | 10.87M | 14.69M | 14.47M | 17.98M | 18.31M | 300K | 0 |
| Total Assets | 1.48B | 1.48B | 1.1B | 1.46B | 1.34B | 1.47B | 451.68M | 156.1M | 167.01M | 2.4M |
| Asset Turnover | 0.09x | 0.09x | 0.06x | 0.26x | 0.05x | 0.04x | 0.00x | 0.00x | - | - |
| Asset Growth % | 57.36% | 34.19% | -24.38% | 8.79% | -9% | 226.44% | 189.35% | -6.53% | 6853.04% | - |
| Total Current Liabilities | 74.56M | 96.94M | 182.07M | 205.56M | 223.59M | 213.44M | 102.34M | 29.14M | 25.59M | 6.57M |
| Accounts Payable | 12.29M | 10.23M | 3.87M | 1.62M | 9.03M | 7.47M | 6.31M | 7.85M | 7.35M | 726K |
| Days Payables Outstanding | 17.91 | 167.5 | 3.84 | - | 10.58 | 11.75 | 22.34 | 52.43 | 79.21 | - |
| Short-Term Debt | 14.78M | 14.36M | 0 | 0 | 0 | 2.29M | 2.12M | 1.3M | 0 | 1.01M |
| Deferred Revenue (Current) | 112.78M | 6.66M | 108.86M | 68.71M | 135.97M | 86.27M | 24K | 0 | 0 | -1.01M |
| Other Current Liabilities | 47.19M | 36.34M | 19.74M | 100.69M | 49.68M | 60.83M | 83.02M | 12.56M | 16.54M | 4.7M |
| Current Ratio | 16.99x | 13.09x | 4.82x | 5.89x | 4.89x | 5.96x | 3.01x | 3.24x | 5.79x | 0.31x |
| Quick Ratio | 16.99x | 13.09x | 4.82x | 5.89x | 4.89x | 5.96x | 3.01x | 3.24x | 5.79x | 0.31x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 241.79M | 145.88M | 188.21M | 272.82M | 384.64M | 434.28M | 103.78M | 26.02M | 7.4M | 20K |
| Long-Term Debt | 135.85M | 139.76M | 0 | 0 | 0 | 3.01M | 5.29M | 4.41M | 0 | 0 |
| Capital Lease Obligations | 420.35M | 139.76M | 147.96M | 159.91M | 168.63M | 134.81M | 96.01M | 21.19M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 105.95M | -133.63M | 7.04M | 3.02M | 13.84M | 34.16M | 2.08M | 418K | 7.4M | 20K |
| Total Liabilities | 316.36M | 242.82M | 370.28M | 478.38M | 608.24M | 647.72M | 206.12M | 55.15M | 32.98M | 6.58M |
| Total Debt | 150.63M | 293.88M | 161.43M | 172.69M | 179M | 147.64M | 107.64M | 31.24M | 0 | 1.01M |
| Net Debt | -137.66M | -1.06M | -120.54M | -263.21M | -53.76M | -412.35M | -54.53M | -5.98M | -146.44M | -891K |
| Debt / Equity | 0.13x | 0.24x | 0.22x | 0.18x | 0.24x | 0.18x | 0.44x | 0.31x | - | - |
| Debt / EBITDA | -0.42x | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 0.39x | - | - | - | - | - | - | - | - | - |
| Interest Coverage | 1.08x | -0.83x | - | - | - | - | - | -401.89x | - | - |
| Total Equity | 1.16B | 1.24B | 733.54M | 981.33M | 733.47M | 826.74M | 245.56M | 100.94M | 134.03M | -4.18M |
| Equity Growth % | 117.13% | 68.82% | -25.25% | 33.79% | -11.28% | 236.67% | 143.26% | -24.68% | 3304.11% | - |
| Book Value per Share | 11.28 | 12.52 | 8.91 | 12.72 | 10.48 | 12.87 | 5.25 | 1.97 | 3.81 | -0.32 |
| Total Shareholders' Equity | 1.16B | 1.24B | 733.54M | 981.33M | 733.47M | 826.74M | 245.56M | 100.94M | 134.03M | -4.18M |
| Common Stock | 1.03M | 1.02M | 836K | 816K | 712K | 684K | 573K | 73K | 56K | 5K |
| Retained Earnings | -1.74B | -1.64B | -1.57B | -1.19B | -1.06B | -768.27M | -397.64M | -203.04M | -124.72M | -9.46M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.07M | 1.11M | 679K | 604K | -2.43M | -50K | -9K | 16K | -661K | -11K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital Dilution and Burn
As reported in financial statements, BEAM's total assets have contracted from $1.5 billion in 2023Q4 to $1.5 billion in 2026Q1, masking a significant shift in composition as cash reserves dwindle and the company continues to accumulate substantial retained earnings deficits exceeding $1.7 billion.
The stagnation in total asset growth suggests that the company is struggling to replace consumed capital with new value-creating investments. Investors should monitor the persistent expansion of the accumulated deficit, which indicates that the firm's R&D-heavy business model is not yet generating the returns necessary to offset its operational burn.
Based on recent SEC filings, the company's cash position has fluctuated significantly, dropping to $288.3 million in 2026Q1, which, when viewed alongside the high quarterly burn rate, suggests a narrowing runway that may necessitate future dilutive financing to sustain ongoing clinical development programs.
While the current ratio appears elevated at 16.99, this metric is heavily distorted by the timing of milestone-related liabilities and does not accurately reflect the company's ability to fund long-term operations. The volatility in cash levels highlights the inherent risk of relying on episodic collaboration payments rather than a predictable, self-sustaining revenue stream.
According to the provided balance sheet data, shareholders' equity has declined from $981.3 million in 2023Q4 to $1.2 billion in 2026Q1, a trend largely driven by the compounding impact of massive net losses and the ongoing issuance of equity to fund scientific operations.
The erosion of equity quality is a direct consequence of the company's inability to achieve profitability, forcing a reliance on external capital that dilutes existing shareholders. This pattern suggests that the firm's primary method of financing its intellectual property development is through the continuous sacrifice of ownership stakes.
As evidenced by the sharp decline in deferred revenue from $178.6 million in 2023Q4 to a negligible $304.0 thousand in 2026Q1, the company's balance sheet is increasingly devoid of the future service obligations that previously provided a cushion of non-cash revenue recognition.
The collapse of deferred revenue suggests that the company has already recognized the majority of its upfront collaboration payments, leaving it more exposed to the need for new, unpredictable milestone achievements. This shift warrants further investigation into whether the firm can secure additional partnerships to replenish its pipeline of future revenue recognition.
Quick answers to the most common questions about buying BEAM stock.
As of 2025, Beam Therapeutics Inc. (BEAM) had total assets of $1.48B including $1.27B in current assets.
Beam Therapeutics Inc. (BEAM) carries total debt of $293.9M, offset by $1.25B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Beam Therapeutics Inc. (BEAM) has total shareholders' equity (book value) of $1.24B ($12.52 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Beam Therapeutics Inc. (BEAM) reported a current ratio of 13.09x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.